Karyopharm Therapeutics Inc. Reports annual revenue of $146.0 million
Company Records $143,099,000.0 loss
By USInMinutes
Published - Feb 29, 2024, 12:40 PM ET
Last Updated - Feb 29, 2024, 12:40 PM EST
Karyopharm Therapeutics Inc. [KPTI] has reported $146.0 million in revenue for year ended Dec 31, 2023.
Also Read:
